close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about OCUL

Recent news which mentions OCUL

< Previous 1 2 3 4 5 Next >
Expert Ratings for Ocular Therapeutix
Tickers OCUL
Tags Benzinga OCUL BZI/AAR
From Benzinga
Earnings Scheduled For May 9, 2022
Tickers IFF III IIIV ITUB
Tags TRUE MRSN IFF
From Benzinga
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
Tickers ACAD AQST BIIB BLTE
Tags RIGL Biotech Guidance
From Benzinga
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More
Tickers AGTC AMGN AMRN ATHX
Tags ILMN BIIB FDA
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Tickers ACON ALNA BLRX CABA
Tags CABA Benzinga ACON
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
Tickers HLBZ HNST HYFM HYRE
Tags KERN OCUL RMBL
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Tickers ACLX ADVM AFCG ALLK
Tags AMSC SIEN MREO
From Benzinga
The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More
Tickers ABT ANTX GSK IBB
Tags TGTX KLDO Earnings
From Benzinga
Recap: Ocular Therapeutix Q4 Earnings
Tickers OCUL
Tags Benzinga BZI/Recaps OCUL
From Benzinga
Earnings Scheduled For February 28, 2022
Tickers AAON ACAD ACHC AGM
Tags FSK APPF AVIR
From Benzinga
Stocks That Hit 52-Week Lows On Friday
Tickers LAWS LAZ LII LOVE
Tags VTYX RMR NLSN
From Benzinga
Ocular Therapeutix's Dexamethasone Ophthalmic Insert Meets Primary Goal In Dry Eye Disease Trial
Tickers OCUL
Tags dry eye disease Biotech Market News
From Benzinga
3 Small-Cap Stocks to Buy Now and Hold for the Long Haul
Tickers NNOX OCUL RNLX
Tags OCUL Market News RNLX
From Motley Fool
Expert Ratings For Ocular Therapeutix
Tickers OCUL
Tags Analyst Ratings Market News BZI/AAR
From Benzinga
Ocular Therapeutix Stock Gains As Court Invalidates Drug Delivery Patent From Mati
Tickers OCUL
Tags General Market News Long Ideas
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Tickers ABSI ACAD ASRT CMPS
Tags Top Gainers Intraday Update CMPS
From Benzinga
Ocular Therapeutix: Q3 Earnings Insights
Tickers OCUL
Tags BZI/Recaps Benzinga OCUL
From Benzinga
Earnings Scheduled For November 8, 2021
Tickers GPMT GTES GWRS HIL
Tags RBLX ICMB VAC
From Benzinga
What 5 Analyst Ratings Have To Say About Ocular Therapeutix
Tickers OCUL
Tags Benzinga BZI/AAR OCUL
From Benzinga
How The Future Looks For Last Week's Biggest Losers: Vinco Ventures, Atea Pharmaceuticals And More
Tickers AVIR BBIG GRTX MTCR
Tags BBIG Trading Ideas AVIR
From Benzinga
10 Biggest Price Target Changes For Monday
Tickers BAC BJRI CCL MSFT
Tags CCL TSLA Small Cap
From Benzinga
55 Biggest Movers From Friday
Tickers AGEN ALTM AUPH BBIG
Tags LLL MSB HX
From Benzinga
Are Atea Pharmaceuticals, Agenus, Novavax, and Ocular Therapeutix Bad News Buy?
Tickers AGEN AVIR BMY DWAC
Tags AGEN OCUL MRK
From Motley Fool
Mid-Afternoon Market Update: Nasdaq Down 70 Points; Ocular Therapeutix Shares Drop
Tickers AXP CRTD DWAC MTCR
Tags SIVB Market News CRTD
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Tickers AGEN ARAY BFRA BPTS
Tags ARAY BTCY CYCCP
From Benzinga
Mid-Day Market Update: Snap Drops After Q3 Results; Creatd Shares Jump
Tickers AXP CRTD DWAC MTCR
Tags Markets Earnings Mid/Day Market Update
From Benzinga
35 Stocks Moving In Friday's Mid-Day Session
Tickers AGEN ALTM ATHA BBIG
Tags Penny Stocks MTCR GROM
From Benzinga
Here's Why Ocular Therapeutix Stock Is Sinking Today
Tickers OCUL
Tags OCUL Market News
From Motley Fool
3 Great Stocks You Can Buy With $50 Right Now
Tickers AMRS DNA OCUL RNLX
Tags ZY DNA AMRS
From Motley Fool
10 Biggest Price Target Changes For Monday
Tickers AR DIS FBHS GS
Tags NTAP GS Price Target Changes
From Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today